Publications - Carterra

Pre-Print Publication

Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38

Peer-Reviewed Publication

Nature Medicine: A candidate antibody drug for prevention of malaria

Peer-Reviewed Publication

Nature Scientific Reports: High‑throughput analysis system of interaction kinetics for data‑driven antibody design

Peer-Reviewed Publication

Widespread monoclonal IgE antibody convergence to an immunodominant, proanaphylactic Ara h 2 epitope in peanut allergy

Peer-Reviewed Publication

Science: Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

Peer-Reviewed Publication

Cell Reports: Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium

Peer-Reviewed Publication

Science: Broadly neutralizing antibodies target the coronavirus fusion peptide

Peer-Reviewed Publication

Nature: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

Peer-Reviewed Publication

Cell Reports: LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Pre-Print Publication

Unlocking de novo antibody design with generative artificial intelligence

Pre-Print Publication

Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype

Pre-Print Publication

Improving antibody affinity using laboratory data with language model guided design

Peer-Reviewed Publication

Science: Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

Peer-Reviewed Publication

Science: LY-CoV555, a Rapidly Isolated Potent Neutralizing Antibody, Provides Protection in a Non-Human Primate Model of SARS-CoV-2 Infection

1
2